3-pyridinaldehyde has been researched along with 2-bromobenzaldehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouillon, A; Cresteil, T; Fontaine, F; Hequet, A; Jolivalt, C; Lesnard, A; Rault, S; Voisin-Chiret, AS | 1 |
| Höfner, G; Huber, SK; Wanner, KT | 1 |
2 other study(ies) available for 3-pyridinaldehyde and 2-bromobenzaldehyde
| Article | Year |
|---|---|
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Proteins; Boronic Acids; Cell Survival; Ciprofloxacin; Culture Media; Drug Resistance, Bacterial; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; KB Cells; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Staphylococcus aureus; Structure-Activity Relationship | 2014 |
Application of the concept of oxime library screening by mass spectrometry (MS) binding assays to pyrrolidine-3-carboxylic acid derivatives as potential inhibitors of γ-aminobutyric acid transporter 1 (GAT1).
Topics: GABA Plasma Membrane Transport Proteins; GABA Uptake Inhibitors; Oximes; Pyrrolidines; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2019 |